Umfang:
Online-Ressource (XIII, 168p. 2 illus. in color, digital)
ISBN:
9781597451345
,
9781283445719
Serie:
SpringerLink
Inhalt:
Gerri S. Hall
Inhalt:
The incidence of fungal infections increases with the increase in antibiotic usage and increasing immunosuppressed populations. There is no longer only one antifungal agent and the response of fungi to various agents is not always predictable. The need for standardized antifungal susceptibility testing, and standardized interpretation of results in conjunction with studies that describe clinical outcomes based on those tools is ever important. "Interactions of Yeasts, Moulds, and Antifungal Agents: How to Detect Resistance" covers the available antifungal agents, how to perform in vi
Anmerkung:
Includes bibliographical references and index
,
Interactions of Yeasts, Moulds, and Antifungal Agents; Preface; Acknowledgments; Contents; Contributors; Chapter 1: Antifungal Agents; 1.1 The Polyenes; 1.1.1 Amphotericin; 1.1.1.1 Brand Names and Formulations; 1.1.1.2 Structure; 1.1.1.3 Primary Uses; 1.1.1.4 Spectrum of Activity; 1.1.1.5 Mechanism of Action; 1.1.1.6 Pharmacokinetics: (Absorption/Distribution/Excretion); 1.1.1.7 Pharmacodynamic Target; 1.1.1.8 Adverse Reactions/Drug Interactions; 1.1.1.9 Drug Interactions; 1.1.1.10 Resistance; 1.1.1.11 MIC Interpretation; 1.1.1.12 Comments; 1.1.2 Nystatin; 1.1.2.1 Brand Name/Formulations
,
1.1.2.2 Primary Uses1.1.2.3 Spectrum of Activity; 1.1.2.4 Mechanism of Action; 1.1.2.5 Pharmacokinetics: (Absorption/Distribution/Excretion); 1.1.2.6 Adverse Reactions/Drug Interactions; 1.1.2.7 Resistance; 1.1.2.8 MIC Interpretations; 1.1.2.9 Comments; 1.2 5-Fluorocytosine (5-FC); 1.2.1 Brand Name/Formulations; 1.2.2 Structure; 1.2.3 Primary Uses; 1.2.4 Spectrum of Activity; 1.2.5 Mechanism of Action; 1.2.6 Pharmacokinetics: (Absorption/Distribution/Excretion); 1.2.7 Pharmacodynamic Target; 1.2.8 Adverse Reactions/Drug Interactions; 1.2.9 Resistance; 1.2.10 MIC Interpretations
,
1.2.11 Comments1.3 The Azoles; 1.3.1 The Imidazoles; 1.3.1.1 Clotrimazole; Brand Name/Formulations; Primary Uses; Spectrum of Activity; Mechanism of Action; Pharmacokinetics: (Absorption/Distribution/Excretion); Adverse Reactions/Drug Interactions; Resistance; MIC Interpretive Criteria; Comments; 1.3.1.2 Miconazole; Brand Name and/or Formulations; Primary Uses; Spectrum of Activity; Mechanism of Action; Pharmacokinetics: (Absorption/Distribution/Excretion); Adverse Reactions/Drug Interactions; Resistance; MIC Interpretations; Comments; 1.3.1.3 Ketoconazole; Brand Name/Formulations
,
Primary UsesSpectrum of Activity; Mechanism of Action; Pharmacokinetics: (Absorption/Distribution/Excretion); Adverse Reactions/Drug Interactions [ 44 ]; Resistance; MIC Interpretations; Comments; 1.3.2 Triazoles; 1.3.2.1 Fluconazole; Brand Names/Formulations; Primary Uses; Spectrum of Activity; Mechanism of Action; Pharmacokinetics: (Absorption/Distribution/Excretion); Pharmacodynamic Target; Adverse Reactions/Drug Interactions; Resistance; MIC Interpretations; Comments; 1.3.2.2 Itraconazole; Brand Names/Formulations; Primary Uses; Spectrum of Activity; Mechanism of Action
,
Pharmacokinetics: (Absorption/Distribution/Excretion)Pharmacodynamic Target; Adverse Reactions/Drug Interactions; Resistance; MIC Interpretation; Comment; 1.3.2.3 Voriconazole; Brand Name/Formulations; Primary Uses; Spectrum of Activity; Mechanism of Action; Pharmacokinetics: (Absorption/Distribution/Excretion); Pharmacodynamic Target; Adverse Reactions/Drug Interactions; Resistance; MIC Interpretations; Comments; 1.3.2.4 Posaconazole; Brand Name/Formulations; Primary Uses; Spectrum of Activity; Mechanism of Action; Pharmacokinetics: (Absorption/Distribution/Excretion); Pharmacodynamic Target
,
Adverse Reactions/Drug Interactions
Weitere Ausg.:
ISBN 9781588298478
Weitere Ausg.:
Buchausg. u.d.T. ISBN 9781588298478
Sprache:
Englisch
DOI:
10.1007/978-1-59745-134-5
URL:
Volltext
(lizenzpflichtig)
Bookmarklink
